Dr Carolyn Taylor
BM BCh (oxon) MA MRCP FRCR DPhil
Associate Professor, Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and clinical research fellow. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008. She works in the Early Breast Cancer Trialists’ Collaborative Group on trials of surgery and radiotherapy and in a Cancer Research UK research program on the benefits and risks of breast cancer treatments.
Trastuzumab for HER2-positive early stage breast cancer: a meta-analysis of individual patient data from 13,864 women from seven randomised trials
GRAY R. et al, (2021), The Lancet Oncology
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophageal doses published 2013–2018
Duane F. et al, (2020), European Journal of Cancer, 138, S83 - S84
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Henson KE. et al, (2020), Int J Cancer
Heart failure after treatment for breast cancer.
Boekel NB. et al, (2019), Eur J Heart Fail
Eligibility for Partial Breast Radiotherapy in England.
Taylor CW. et al, (2019), Clin Oncol (R Coll Radiol)